Back

eATP/P2X7R axis drives nanoparticle induced neutrophil recruitment in the pulmonary microcirculation

Li, C.; Liu, Q.; Han, L.; Immler, R.; Rathkolb, B.; Secklehner, J.; Hrabe de Angelis, M.; Yildirim, A. O.; Nicke, A.; Carlin, L. M.; Sperandio, M.; Stoeger, T.; Rehberg, M.

2024-03-13 immunology
10.1101/2024.03.11.584398 bioRxiv
Show abstract

Exposure to nanoparticles (NPs) is frequently associated with adverse cardiovascular effects. In contrast, NPs in nanomedicine hold great promise for precise lung-specific drug delivery, especially considering the extensive pulmonary capillary network that facilitates interactions with bloodstream-suspended particles. Therefore, exact knowledge about interactions and effects of engineered NPs with the pulmonary microcirculation are instrumental for future application of this technology in patients. To unravel the real-time dynamics of intravenously delivered NPs and their effects in the pulmonary microvasculature, we employed intravital microscopy of the mouse lung. PEG amine-modified quantum dots (aQDs) with a low potential for biomolecule and cell interactions and carboxyl-modified quantum dots (cQDs) with a high interaction potential were used, representing two different NP subtypes. Only aQDs triggered rapid neutrophil recruitment in microvessels and their subsequent recruitment to the alveolar space. Application of specific inhibitors revealed that the aQDs induced neutrophil recruitment was linked to cellular degranulation, TNF-, and DAMP release into the circulation, particularly extracellular ATP (eATP). Stimulation of the ATP-gated P2X7R induced the expression of E-selectin on microvascular endothelium with the subsequent E-selectin depended neutrophilic immune response. Leukocyte integrins (LFA-1 and MAC-1) mediated adhesion and reduction in neutrophil crawling velocity on the vascular surface. In summary, this study unravels the complex cascade of neutrophil recruitment during NP-induced sterile inflammation. Thereby we demonstrate novel adverse effects for NPs in the pulmonary microcirculation and provide critical insights for optimizing NP-based drug delivery and therapeutic intervention strategies, to ensure their efficacy and safety in clinical applications. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=132 SRC="FIGDIR/small/584398v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@d10acborg.highwire.dtl.DTLVardef@1bbfe7org.highwire.dtl.DTLVardef@1d3e415org.highwire.dtl.DTLVardef@2328de_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Journal of Controlled Release
39 papers in training set
Top 0.1%
38.5%
2
Advanced Functional Materials
41 papers in training set
Top 0.2%
10.3%
3
Nanoscale Advances
13 papers in training set
Top 0.1%
4.4%
50% of probability mass above
4
ACS Nano
99 papers in training set
Top 1%
3.7%
5
ACS Biomaterials Science & Engineering
37 papers in training set
Top 0.2%
3.7%
6
Biomaterials Science
21 papers in training set
Top 0.2%
3.1%
7
Advanced Healthcare Materials
71 papers in training set
Top 0.9%
1.9%
8
Small
70 papers in training set
Top 0.3%
1.9%
9
Theranostics
33 papers in training set
Top 0.5%
1.9%
10
Advanced Materials
53 papers in training set
Top 1%
1.9%
11
Advanced Science
249 papers in training set
Top 9%
1.9%
12
Biomaterials Advances
20 papers in training set
Top 0.3%
1.7%
13
Advanced Therapeutics
15 papers in training set
Top 0.2%
1.7%
14
Biosensors and Bioelectronics
52 papers in training set
Top 1.0%
1.2%
15
Nanoscale
39 papers in training set
Top 0.3%
1.0%
16
iScience
1063 papers in training set
Top 24%
1.0%
17
Nature Nanotechnology
30 papers in training set
Top 1.0%
0.8%
18
ACS Applied Materials & Interfaces
39 papers in training set
Top 0.9%
0.8%
19
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 9%
0.8%
20
Pharmaceutics
21 papers in training set
Top 0.4%
0.8%
21
Frontiers in Immunology
586 papers in training set
Top 8%
0.7%
22
ChemBioChem
50 papers in training set
Top 1%
0.7%
23
eLife
5422 papers in training set
Top 59%
0.7%
24
Integrative Biology
13 papers in training set
Top 0.2%
0.7%
25
Scientific Reports
3102 papers in training set
Top 78%
0.7%
26
Small Methods
26 papers in training set
Top 1%
0.7%
27
Molecular Therapy Nucleic Acids
32 papers in training set
Top 1%
0.5%
28
Nature Communications
4913 papers in training set
Top 67%
0.5%
29
Molecular Pharmaceutics
16 papers in training set
Top 0.7%
0.5%